Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Furthermore, serum 25(OH)D levels were significantly depressed in the sepsis group, with an average of 18.002 ± 8.629 compared to the control group’s 24.822 ± 9.663 (p = 0.007).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This was a single-center cross-sectional study conducted in the Department of Emergency Medicine of the Affiliated Hospital of Guilin Medical University.

Source: Methods.

Participants were consecutively recruited between February 2022 and February 2023 before the initiation of treatment.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Association between serum 25-hydroxyvitamin D, nutritional status, and inflammatory markers in sepsis patients with and without sarcopenia

Cross-sectional study · Frontiers in Medicine · 2026

Original publication title

Association between serum 25-hydroxyvitamin D, nutritional status, and inflammatory markers in sepsis patients with and without sarcopenia

Hong Zheng; Chaoyong Bei; Zhongcheng Mo; Bing Wei

Copyright © 2026 Zheng, Bei, Mo and Wei.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Malnutrition and inflammation were common in patients with sepsis and appeared to be more pronounced in those with concomitant sarcopenia. Serum 25(OH)D levels were associated with nutritional status and inflammatory markers in patients with sepsis, particularly in those with sarcopenia, suggesting that 25(OH)D may serve as a potential biomarker reflecting these clinical features. However, because of the single-center cross-sectional design and limited sample size, these findings should be interpreted with caution. Larger multicenter prospective studies are needed to validate these associations and to further determine the clinical relevance of vitamin D in this population.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, characterized by complex immune dysfunction and inflammatory responses (1, 2). In addition to systemic inflammation, sepsis is also accompanied by profound metabolic disturbances and immune imbalance, both of which may influence clinical outcomes (1). The pathogenesis of this condition is multifaceted and not yet fully understood. In recent years, the potential role of vitamin D (VD) in the pathogenesis of sepsis has garnered significant interest.

Evidence suggests that VD exerts its influence not only on immune cells but also on a variety of cellular types pivotal to bone and mineral metabolism (3, 4). The regulatory function of VD in modulating immune responses and combating infection is well-documented, and its interplay with inflammatory pathways is a subject of extensive research (5Not reported7). Although the precise mechanisms remain incompletely understood, growing evidence suggests that vitamin D may influence sepsis-related immune and inflammatory responses through modulation of innate and adaptive immunity, cytokine production, and antimicrobial defense.

In observational studies, low serum 25-hydroxyvitamin D (25[OH]D) levels have been associated with a higher risk and greater severity of sepsis, as well as with increased inflammatory burden (8Not reported10).

Since the 1980s, a high prevalence of sarcopenia: characterized by progressive muscle mass and function decline: has been reported among the elderly (11). Sarcopenia is intricately linked to age-related physiological alterations, malnutrition, chronic illnesses, inflammation, and lifestyle factors (12). Emerging research suggests that VD deficiency may be associated with the development and progression of sarcopenia, with low VD levels implicated not only in bone metabolism but also in skeletal muscle physiology. VD may affect muscle health through multiple pathways, including muscle protein synthesis, mitochondrial function, calcium homeostasis, and the modulation of inflammatory signaling.

Furthermore, its regulatory impact on immune function and inflammatory responses may also contribute to the development of sarcopen (13).

Recent investigations have suggested a link between sarcopenia and the onset and severity of sepsis (14, 15). Patients with sepsis often exhibit immune dysregulation, pronounced inflammatory responses, catabolic stress, reduced mobility, and nutritional insufficiency, all of which may contribute to accelerated muscle loss and the development of sarcopenia (16, 17). Conversely, those with sarcopenia are at an increased risk of malnutrition and immune dysfunction at sepsis onset, potentially related to VD’s role in immune modulation and nutrient metabolism (18).

Collectively, these findings suggest that VD deficiency may be associated with both sepsis and sarcopenia, possibly through shared pathways involving immune dysregulation, inflammation, and altered muscle metabolism (19, 20). While the exact role of VD in sepsis and sarcopenia requires further investigation, current evidence supports a potential link between VD status, immune responses, and nutritional/metabolic disturbances in these conditions (21).

The potential clinical relevance of VD deficiency in sepsis and sarcopenia has attracted increasing attention (22, 23). Systematic reviews and meta-analyses have supported an association between VD deficiency and both sepsis and sarcopenia, although these findings are largely based on observational evidence (24, 25). Although several studies have explored the potential role of VD as a biomarker, data on clinically relevant 25(OH)D thresholds in patients with sepsis, particularly those with sarcopenia, remain limited (26Not reported30).

The current study aimed to address this gap by exploring 25(OH)D cut-off values with potential discriminatory value for sepsis and sepsis with sarcopenia, particularly in a Chinese patient population where relevant data remain scarce.

Given the reported associations of VD with nutritional status and inflammation, serum 25(OH)D may have potential value as a biomarker reflecting nutritional and inflammatory status in patients with sepsis and comorbid sarcopenia. Therefore, this study evaluated VD levels in relation to nutritional status and inflammatory markers and further explored their potential discriminatory value by estimating 25(OH)D cut-off values.

Source: Introduction Source: Introduction Source: Introduction Source: Introduction Source: Introduction

Study methods

What methods does the paper describe?

2.2

Patients

This was a single-center cross-sectional study conducted in the Department of Emergency Medicine of the Affiliated Hospital of Guilin Medical University. A total of 100 patients with sepsis were enrolled, including 46 patients with concomitant sarcopenia. Participants were consecutively recruited between February 2022 and February 2023 before the initiation of treatment. Eligible sepsis patients were consecutively screened and recruited in the Department of Emergency Medicine during the study period, and healthy controls were recruited during the same period as the comparative group.

The sample size was determined by the number of eligible participants who were consecutively recruited during the study period.

The inclusion criteria for the sepsis group were consecutive patients admitted during the study period who met the Sepsis-3 diagnostic criteria and had not initiated treatment at the time of enrollment. The exclusion criteria were incomplete clinical or laboratory data and inability to provide informed consent. Healthy controls were recruited during the same period and had no evidence of acute infection or sepsis at enrollment. The sepsis diagnosis was ascertained through a synthesis of clinical assessments, biochemical analyses, bacteriological examinations, and histological evaluations, in strict accordance with the Sepsis-3 criteria established in 2016.

For the detection of sarcopenia in the sepsis cohort, a multifaceted approach was employed, integrating clinical presentations, thorough physical examinations, diagnostic imaging, and the authoritative guidelines provided by the Asian Working Group on Sarcopenia (AWGS) as outlined in their 2019 Consensus on the Diagnosis and Treatment of Sarcopenia. Specifically, the diagnosis was based on objective assessments of muscle mass, muscle strength, and physical performance in accordance with the AWGS 2019 criteria. Concurrently, a control group comprising 92 healthy volunteers was assembled to serve as a comparative reference in the study.

2.3

Measurements

Sarcopenia-related assessments included the evaluation of muscle mass, muscle strength, and physical performance according to the AWGS 2019 criteria. Nutritional status was assessed using the Nutritional Risk Screening 2002 (NRS-2002), the Scored Patient-Generated Subjective Global Assessment (PG-SGA), and Body Mass Index (BMI). These tools were used to comprehensively evaluate nutritional risk and nutritional status in the study participants. The NRS-2002 was used to screen for nutritional risk, and a score of ≥3 was considered indicative of nutritional risk. The PG-SGA was used to evaluate nutritional status, and a score of ≥4 was considered indicative of malnutrition.

Anthropometric measurements, height and weight, were recorded with precision to the nearest 0.1 cm and 0.1 kg, respectively, using standardized scales while participants were barefoot and unclothed save for light attire. BMI was calculated using the formula weight in kilograms divided by the square of height in meters. The classification of BMI was as follows: underweight (BMI < 18.5 kg/m2), normal weight (18.5 kg/m2 ≤ BMI < 25 kg/m2), overweight (25 kg/m2 ≤ BMI < 30 kg/m2), and obese (BMI ≥ 30 kg/m2), with underweight being indicative of a nutritional deficiency.

Furthermore, we utilized the Sequential Organ Failure Score (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II), and the Nutritional Risk Score for the Critically Ill Patient (NUTRIC), along with metrics for the incidence of septic shock and the 28-day survival rate, to gauge the inflammatory response and the severity of sepsis. The SOFA score quantified the extent of organ dysfunction, with higher scores correlating with increased infection severity and organ failure. The APACHE II score evaluated the overall disease severity, with higher scores foretelling graver conditions and a more adverse prognosis.

The NUTRIC score assessed the nutritional risk and concurrent disease severity in critically ill patients, with higher scores reflecting greater nutritional risk and more intense disease manifestations.

Laboratory data encompassed measurements of Total Protein (TP), Albumin (ALB), C-reactive protein (CRP), Procalcitonin (PCT), Interleukin-6 (IL-6), and serum 25-hydroxyvitamin D (25[OH]D). CRP and IL-6 were quantified using the Enzyme-Linked Immunosorbent Assay (ELISA), Serum 25(OH)D levels were measured by radioimmunoassay using a DiaSorin analyzer (DiaSorin, Stillwater, MN, USA), PCT levels were determined by chemiluminescence, and TP and ALB were measured using standard biochemical methods. Data collection was uniformly conducted in the morning following an 8: to 12-h fasting period, with each participant assessed by the same researcher to ensure consistency.

Blood samples were systematically collected in 5 mL anticoagulant-free sodium heparin tubes and anticoagulant-free tubes. A qualified physician was responsible for the routine collection of medical history and the assessment of nutritional and inflammatory biomarkers.

2.4

Statistical analysis

Statistical analysis was performed utilizing SPSS version 26.0 (IBM Corp., Armonk, NY, USA). We employed descriptive statistical measures to delineate the demographic and clinical characteristics of the study sample. Quantitative variables were summarized as means and standard deviations, and categorical variables were presented as numbers and percentages. Comparative analyses of indicators between groups were executed using Student’s t-test for variables exhibiting normal distribution, while the Mann: Whitney U test was applied for variables that did not adhere to normal distribution.

Categorical variables were compared using the chi-square test or Fisher’s exact test, as appropriate. The assessment of correlations between various indicators was conducted through linear regression for continuous variables and binary logistic regression analysis for categorical outcomes. Statistical significance was set at the p-value threshold of less than 0.05.

Graphical representations of the data were crafted using GraphPad Prism software, version 8.0.2 (GraphPad Software, San Diego, CA, USA). A receiver operating characteristic (ROC) analysis was implemented to evaluate the diagnostic sensitivity and specificity of serum 25-hydroxyvitamin D (25[OH]D) levels in distinguishing sepsis and sepsis with sarcopenia. This analysis also served to identify the optimal cut-off value for vitamin D levels and to explore their potential discriminatory value.

Source: Materials and methods Source: Materials and methods Source: Materials and methods

Highlights

  • This investigation provides a nuanced understanding of the relationship between VD deficiency, sarcopenia, and sepsis, accentuating the significance of VD in immune modulation.

  • It reveals pronounced differences in serum 25(OH)D levels and related inflammatory and nutritional indicators among sepsis patients, with and without sarcopenia, in contrast to control subjects.

  • The study delineates superior VD threshold criteria for sepsis and its concomitant sarcopenia, highlighting the clinical relevance of VD measurements in the diagnosis and morbidity forecasting for these patient groups.

Source: Highlights

Discussion

In the current investigation, a high prevalence of severe malnutrition and inflammatory conditions was noted among patients with sepsis, corroborating previous studies (31Not reported33). The ubiquity of malnutrition in this patient population is underscored by diminished BMI and reduced levels of TP and ALB (34Not reported36). Concurrently, pronounced inflammatory responses are indicated by increased serum concentrations of CRP, PCT and IL-6 (37Not reported41). These observations are in line with existing literature that recognizes inflammation and malnutrition as prevalent clinical manifestations in sepsis, suggesting their integral roles in the pathophysiology of the condition and their potential influence on the evolution and severity of sepsis (42, 43).

This study further revealed that the sepsis cohort with comorbid sarcopenia exhibited exacerbated malnutrition and more adverse clinical outcomes. Patients in this subgroup were characterized by an elevated mean age, higher nutritional scores as measured by the NRS-2002 and PG-SGA, and a decreased BMI. These findings imply a close relationship between malnutrition and the development and exacerbation of sarcopenia in sepsis patients. Prior research has also established a higher incidence of malnutrition in sarcopenic patients, with nutritional status being intricately linked to sarcopenia severity (11, 44).

These findings underscore the importance of nutritional and muscle-related assessments in patients with sepsis, particularly in those with sarcopenia. However, given the cross-sectional design of the present study, the observed associations should not be interpreted as evidence of causality or as proof of intervention efficacy.

Serum 25(OH)D levels were identified as a significant parameter in this study, with sepsis patients showing significantly lower levels compared to controls. A negative correlation was observed between 25(OH)D levels and the onset and progression of sepsis. Notably, the subgroup of patients with sepsis and myasthenia gravis presented with even lower 25(OH)D levels, aligning with previous findings that have reported reduced levels in sepsis (7, 45Not reported47) and myasthenia gravis (10, 48Not reported50) patients.

These data hint at a pivotal role for 25(OH)D in the pathogenesis of sepsis, with its deficiency potentially contributing to malnutrition and sarcopenia in affected patients.

Nutritional support remains an important component of sepsis care, and previous studies have explored its possible relationship with clinical outcomes (51Not reported55). However, the present study did not evaluate the effects of vitamin D supplementation or nutritional intervention. Therefore, our findings should be interpreted as observational associations only, and the potential benefits of these interventions in patients with sepsis and sarcopenia require confirmation in prospective interventional studies.

This study has several limitations. First, it was conducted at a single center, and the study population was derived from one hospital, which may limit the generalizability of the findings to other regions, healthcare settings, or patient populations. Second, the sample size was relatively limited, particularly for subgroup analyses, which may reduce the robustness of the statistical analyses and increase the possibility of random error or type II error. Third, because this was a cross-sectional study, the observed associations between serum 25(OH)D levels and nutritional or inflammatory indicators should be interpreted as correlations rather than causal relationships.

In addition, potential confounding factors affecting serum 25(OH)D levels, such as sunlight exposure, previous vitamin D supplementation, seasonal variation, and metabolic comorbidities, were not systematically collected or controlled for in the present study. Finally, dynamic changes in vitamin D status and the effects of interventions were not evaluated. Therefore, larger multicenter prospective studies are needed to validate the present findings and further clarify the clinical relevance of vitamin D in patients with sepsis and sarcopenia.

Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion

Results

Upon examination of the data presented in Figure 1. The detailed underlying data are provided in Table 1, several notable clinical distinctions emerged between sepsis patients and the control group. The average age of individuals in the sepsis cohort, at 68.630 ± 14.263 years, was marginally elevated in comparison to the control group’s average of 65.577 ± 5.916 years; however, this variance did not reach a level of statistical significance (p = 0.066).

Figure 1

Demographic and clinical characteristics of sepsis and control patients.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Demographic and clinical characteristics of sepsis and control patients.

CharacteristicSepsisControl P
N (male/female)100 (65/35)92 (62/30)Not reported
Age (years)68.630 ± 14.26365.577 ± 5.9160.066
NRS-20023.410 ± 1.4780.120 ± 0.435<0.001
PG-SGA7.920 ± 5.5131.308 ± 3.723<0.001
BMI (kg/m2)20.614 ± 5.16124.458 ± 3.585<0.001
TP (g/L)69.297 ± 8.38271.589 ± 4.6380.032
ALB (g/L)36.302 ± 6.42941.741 ± 2.456<0.001
CRP (mg/L)48.306 ± 53.5822.834 ± 8.474<0.001
PCT (ng/mL)6.152 ± 20.9280.119 ± 0.1750.005
IL-6 (pg/mL)80.358 ± 208.4782.662 ± 2.392<0.001
Serum 25(OH)D (ng/mL)18.002 ± 8.62924.822 ± 9.6630.007

Data are mean values ± standard deviation (SD). NRS-2002: Nutrition Risk Screening 2002; PG-SGA score: Patient-Generated Subjective Global Assessment score; BMI: Body Mass Index; TP: Total Protein; ALB: Albumin; CRP: C-reactive protein; PCT: Procalcitonin; IL-6: Interleukin 6. p-values were calculated using Student’s t-test for normally distributed variables or Mann: Whitney U test for those not normally distributed. Differences were considered significant at p < 0.05.

Significant disparities were observed in the NRS-2002 and PG-SGA scores, with the sepsis group consistently demonstrating higher scores: 3.410 ± 1.478 versus 0.120 ± 0.435 (p < 0.001) for NRS-2002, and 7.920 ± 5.513 versus 1.308 ± 3.723 (p < 0.001) for PG-SGA, respectively. Additionally, the body mass index (BMI) of the sepsis group was markedly reduced compared to the control group, with respective averages of 20.614 ± 5.161 and 24.458 ± 3.585 (p < 0.001), indicating a pronounced malnutrition profile.

Biochemical indices further delineated the divergence between the two groups. The sepsis group exhibited significantly diminished levels of TP and ALB, with averages of 69.297 ± 8.382 and 36.302 ± 6.429, contrasting with the control group’s 71.589 ± 4.638 and 41.741 ± 2.456 (p = 0.032 for TP, p < 0.001 for ALB). Conversely, the sepsis group displayed elevated levels of CRP, PCT, and IL-6: 48.306 ± 53.582 versus 2.834 ± 8.474 (p < 0.001) for CRP, 6.152 ± 20.928 versus 0.119 ± 0.175 (p = 0.005) for PCT, and 80.358 ± 208.478 versus 2.662 ± 2.392 (p < 0.001) for IL-6.

Furthermore, serum 25(OH)D levels were significantly depressed in the sepsis group, with an average of 18.002 ± 8.629 compared to the control group’s 24.822 ± 9.663 (p = 0.007).

In essence, the clinical and biochemical profiles of sepsis patients reveal a starkly malnourished and inflammatory phenotype, which may be intricately connected to the etiology and clinical progression of sepsis.

The data were analyzed to discern the impact of sarcopenia on sepsis patients, with the sepsis cohort stratified into those with and without sarcopenia for a comparative study. As delineated in Figure 2. The detailed underlying data are provided in Table 2, substantial disparities were noted between these two subgroups within the sepsis population.

Figure 2

Demographic and clinical characteristics of patients with sepsis.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 2

Demographic and clinical characteristics of patients with sepsis.

CharacteristicSepsis with sarcopeniaSepsis without sarcopenia p
N (male/female)46 (32/14)54 (35/19)Not reported
Age (years)73.500 ± 10.67264.481 ± 15.584<0.001
NRS-20024.391 ± 1.2732.574 ± 1.070<0.001
PG-SGA9.783 ± 5.5816.333 ± 4.9520.001
BMI (kg/m2)16.139 ± 2.16724.426 ± 3.668<0.001
SOFA3.913 ± 2.3173.130 ± 1.6410.041
APACHE II14.022 ± 6.07210.333 ± 5.1520.001
NUTRIC2.696 ± 1.8241.852 ± 1.3450.006
The incidence rate of septic shock (%)15.217 (7/46)1.852 (1/54)0.003
28-day survival rate (%)67.391 (31/46)94.444 (51/54)<0.001
TP (g/L)67.462 ± 9.38370.860 ± 7.1140.031
ALB (g/L)34.538 ± 6.43237.804 ± 6.0620.004
CRP (mg/L)60.147 ± 51.40738.439 ± 53.5680.021
PCT (ng/mL)12.284 ± 30.1571.157 ± 2.6540.019
IL-6 (pg/mL)131.084 ± 296.87937.289 ± 48.5540.041
Serum 25(OH)D (ng/mL)15.222 ± 7.05420.559 ± 9.159<0.001

Data are presented as mean ± standard deviation (SD). NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6. Statistical significance was determined using Student’s t-test for normally distributed variables or Mann: Whitney U test for non-normally distributed variables, with differences considered significant at p < 0.05.

The mean age of the sepsis group complicated by sarcopenia (73.500 ± 10.672 years) was notably elevated compared to the sepsis group without sarcopenia (64.481 ± 15.584 years), with this difference attaining statistical significance (p < 0.001). The sepsis group with sarcopenia also exhibited markedly higher scores in the NRS-2002 and PG-SGA assessments, with respective values of 4.391 ± 1.273 versus 2.574 ± 1.070 (p < 0.001) and 9.783 ± 5.581 versus 6.333 ± 4.952 (p = 0.001).

Furthermore, this group demonstrated a significantly reduced BMI (16.139 ± 2.167 vs. 24.426 ± 3.668, p < 0.001), underscoring a pronounced malnutrition phenotype.

Clinical scoring systems indicated a trend towards higher severity in the sepsis group with sarcopenia, as evidenced by the SOFA score (3.913 ± 2.317 vs. 3.130 ± 1.641, p = 0.041) and APACHE II score (14.022 ± 6.072 vs. 10.333 ± 5.152, p = 0.001). Similarly, the NUTRIC score was modestly elevated in the sepsis group with sarcopenia (2.696 ± 1.824 vs. 1.852 ± 1.345, p = 0.006). Clinical outcome parameters included the incidence of septic shock and the 28-day survival rate.

The rate of septic shock was significantly more prevalent in the sepsis group with sarcopenia (15.217% vs. 1.852%, p = 0.003), while the 28-day survival rate was considerably lower in this group (67.391% vs. 94.444%, p < 0.001), indicating a poorer prognosis.

Biochemical parameters revealed that levels of TP and ALB were significantly lower, whereas CRP, PCT, and IL-6 were significantly higher in the sepsis group with sarcopenia compared to the non-sarcopenia group, with respective values of 67.462 ± 9.383 vs. 70.860 ± 7.114 (p = 0.031), 34.538 ± 6.432 vs. 37.804 ± 6.062 (p = 0.004), 60.147 ± 51.407 vs. 38.439 ± 53.568 (p = 0.021), 12.284 ± 30.157 vs. 1.157 ± 2.654 (p = 0.019), and 131.084 ± 296.879 vs. 37.289 ± 48.554 (p = 0.041).

Additionally, serum 25(OH)D levels were significantly reduced in the sepsis group with sarcopenia (15.222 ± 7.054 vs. 20.559 ± 9.159, p < 0.001).

In summary, sepsis patients with concomitant sarcopenia displayed significant malnutrition, a robust inflammatory response, and a higher incidence of septic shock coupled with a diminished survival rate. These clinical features and biochemical indices suggest a strong correlation between sarcopenia and adverse outcomes in sepsis.

The regression analyses elucidating the relationships between serum 25(OH)D levels and various indices are show in Figure 3, The detailed underlying data are provided in Table 3. This table encapsulates the findings from regression models assessing the association of serum 25(OH)D with nutritional and inflammatory markers across different groups: sepsis patients, those with sepsis and sarcopenia, those with sepsis without sarcopenia, and a control cohort. In the sepsis group, serum 25(OH)D exhibited a significant negative correlation with the NRS-2002, PG-SGA, SOFA, APACHE II, and NNUTRIC scores.

Conversely, it demonstrated a positive correlation with BMI, TP, and ALB.

Figure 3

Regression analysis between serum 25(OH)D and nutritional, inflammatory indicators for total sepsis, sepsis with sarcopenia, sepsis without sarcopenia and control groups.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 3

Regression analysis between serum 25(OH)D and nutritional, inflammatory indicators for total sepsis, sepsis with sarcopenia, sepsis without sarcopenia and control groups.

CharacteristicSepsisSepsis with sarcopeniaSepsis without sarcopeniaControl
β p β p β p β p
NRS-2002−0.381<0.001−0.3490.017−0.2570.010−0.1150.567
PG-SGA−0.694<0.001−0.882<0.001−0.599<0.0010.1250.512
BMI (kg/m2)0.2210.0070.3820.009−0.0630.531−0.0500.793
SOFA−0.2530.002−0.508<0.001−0.0840.404Not reportedNot reported
APACHE II−0.314<0.001−0.4220.004−0.1760.080Not reportedNot reported
NUTRIC−0.319<0.001−0.519<0.001−0.1560.122Not reportedNot reported
TP (g/L)0.1680.0420.3640.0130.0140.894−0.0720.722
ALB (g/L)0.377<0.0010.501<0.0010.2840.0040.1630.416
CRP (mg/L)−0.480<0.001−0.3800.010−0.486<0.001−0.4790.012
PCT (ng/mL)−0.2700.001−0.4650.0010.0840.4070.4950.005
IL-6 (pg/mL)−0.307<0.001−0.4060.006−0.3330.001−0.604<0.001

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Among the sepsis patients with sarcopenia, the negative correlation between serum 25(OH)D and inflammatory markers was more pronounced, with correlation coefficients of β = −0.380 for CRP (p = 0.010), β = −0.465 for PCT (p = 0.001), and β = −0.406 for IL-6 (p = 0.006), indicating a stronger relationship with inflammatory burden. In contrast, in the sepsis group without sarcopenia, serum 25(OH)D was also negatively correlated with CRP (β = −0.486, p < 0.001) and IL-6 (β = −0.333, p = 0.001), whereas the association with PCT was not statistically significant (β = 0.084, p = 0.407).

In the control group, serum 25(OH)D levels were negatively associated with the NRS-2002, PG-SGA, CRP, and IL-6, while a positive association was observed with BMI, TP, ALB, and PCT.

These regression analyses underscore a discernible link between serum 25(OH)D levels and the nutritional and inflammatory profiles of sepsis patients, particularly within the subgroup presenting with both sepsis and sarcopenia. The findings hint at the potential role of vitamin D in modulating the inflammatory and nutritional dynamics in critical illness.

The regression analyses, with the key results visualized in Figures 4 and 5 and the full statistical details provided in Tables 4 and 5, yield several key insights into the interplay between nutritional and inflammatory markers within the sepsis population. In the sepsis group, a correlation was identified between nutritional indicators: encompassing the NRS-2002, PG-SGA, BMI, TP, and ALB: and inflammatory markers, which included the SOFA, APACHE II, NUTRIC, CRP, PCT, and IL-6.

Figure 4

Regression analysis between nutrition indicators and inflammatory markers in sepsis group.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 5

Regression analysis between nutrition indicators and inflammatory markers in sepsis with sarcopenia group.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 4

Regression analysis between nutrition indicators and inflammatory markers in sepsis group.

CharacteristicNRS-2002PG-SGABMI (kg/m2)TP (g/L)ALB (g/L)
β p β p β p β p β p
SOFA0.335<0.0010.2640.001−0.2360.003−0.498<0.001−0.428<0.001
APACHE II0.5430.0060.282<0.001−0.296<0.001−0.383<0.001−0.316<0.001
NUTRIC0.463<0.0010.301<0.001−0.2680.001−0.367<0.001−0.327<0.001
CRP (mg/L)0.332<0.0010.400<0.001−0.1120.167−0.2370.003−0.377<0.001
PCT (ng/mL)0.491<0.0010.397<0.001−0.378<0.001−0.484<0.001−0.384<0.001
IL-6 (pg/mL)0.397<0.0010.381<0.001−0.289<0.001−0.444<0.001−0.364<0.001

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Table 5

Regression analysis between nutrition indicators and inflammatory markers in sepsis with sarcopenia group.

CharacteristicNRS-2002PG-SGABMI (kg/m2)TP (g/L)ALB (g/L)
β p β p β p β p β p
SOFA0.4710.0010.548<0.001−0.4840.001−0.671<0.001−0.504<0.001
APACHE II0.545<0.0010.506<0.001−0.4350.003−0.598<0.001−0.3280.026
NUTRIC0.531<0.0010.546<0.001−0.3450.019−0.530<0.001−0.3280.026
CRP (mg/L)0.4800.0010.4580.002−0.548<0.001−0.631<0.001−0.4870.001
PCT (ng/mL)0.607<0.0010.610<0.001−0.644<0.001−0.674<0.001−0.545<0.001
IL-6 (pg/mL)0.4650.0010.4770.001−0.576<0.001−0.697<0.001−0.565<0.001

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Notably, the NRS-2002, PG-SGA, and BMI scores were found to be positively correlated with the SOFA, APACHE II, and NUTRIC scores, while an inverse relationship was observed with CRP, PCT, and IL-6 levels. This inverse correlation implies that an enhanced nutritional status may correlate with reduced inflammatory activity. Within the subgroup of sepsis patients with sarcopenia, these associations were even more pronounced, indicating that the presence of malnutrition and sarcopenia could be linked to heightened inflammation and a greater risk of organ dysfunction.

The findings from these analyses underscore the intricate relationship between a patient’s nutritional status and systemic inflammation, and they highlight the significance of considering both nutritional and inflammatory parameters in the comprehensive care of sepsis patients. This holistic approach may facilitate more effective treatment strategies and improved patient outcomes.

In the binary logistic regression analysis, the sepsis cohort was bifurcated into two distinct groups based on the presence or absence of sarcopenia, with these groups serving as the dependent variables. The outcomes of this analysis are delineated in Figure 6, The detailed underlying data are provided in Table 6. Serum 25(OH)D levels were significantly associated with sepsis classification in the binary logistic regression model (β = 0.085, OR = 1.089, 95% CI: 1.034 to 1.147, p = 0.001).

The OR was calculated to be 1.089, with a 95% CI ranging from 1.034 to 1.147, indicating that for every unit increase in serum 25(OH)D, there is an 8.9% increase in the odds of a favorable outcome.

Figure 6

Binary logistic regression model addressing the associations between Serum 25(OH)D, nutrition indicators, infection markers and sepsis classification.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 6

Binary logistic regression model addressing the associations between serum 25(OH)D, nutrition indicators, infection markers and sepsis classification.

Characteristic β p ORCI (95%)
Serum 25(OH)D (ng/mL)0.0850.0011.0891.034 to 1.147
NRS-2002−1.103<0.0010.3320.233 to 0.474
PG-SGA−0.1210.0010.8860.826 to 0.950
BMI (kg/m2)1.601<0.0014.9572.448 to 10.040
SOFA−0.2050.0260.8140.680 to 0.975
APACHE II−0.1170.0010.8900.833 to 0.951
NUTRIC−0.3390.0030.7120.569 to 0.892
TP (g/L)0.0550.0181.0561.009 to 1.105
ALB (g/L)0.0860.0041.0901.027 to 1.157
CRP (mg/L)−0.0070.0250.9930.987 to 0.999
PCT (ng/mL)−0.0490.0360.9520.909 to 0.997
IL-6 (pg/mL)−0.0070.0060.9940.989 to 0.998

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Furthermore, nutritional indicators demonstrated a negative correlation with the severity of inflammation, with this association reaching statistical significance (p < 0.05). This suggests that improved nutritional status is inversely related to inflammatory severity, reinforcing the potential mitigating role of adequate nutrition in modulating the inflammatory response in sepsis.

The ROC curve analyses, along with the determination of optimal cut-off values, are illustrated in Figure 7. Notably, significant differences in serum 25(OH)D levels were observed when comparing the sepsis and control groups, as well as between the sepsis with sarcopenia and the sepsis without sarcopenia groups (as depicted in Figures 7a,c). For the sepsis versus control group comparison, the AUC was calculated to be 0.7021, indicating that 25(OH)D demonstrated a sensitivity of 70.0% and a specificity of 72.9%, indicating a moderate discriminatory performance.

In contrast, the AUC for distinguishing the sepsis-combined-sarcopenia group from the non-sarcopenia group was 0.6780, with a sensitivity of 72.0% and a specificity of 56.5%, suggesting a modest discriminatory value.

Figure 7

Analysis of 25(OH)D cut-off values for diagnosing Sepsis. Means and p-values of serum 25(OH)D levels in the sepsis and control groups (a), and the sepsis with Sarcopenia and without Sarcopenia groups (c). The ROC analysis to determine optimal cut-off values in the sepsis and control groups (b), and the sepsis with sarcopenia and without sarcopenia groups (d). ROC, receiver operating characteristic.

Figure image at the original source: open the original paper. This file is not included in this text import.

The optimal cut-off values for 25(OH)D, showing the best discriminatory performance for distinguishing sepsis and sepsis with sarcopenia, were identified as 22.55 ng/mL and 14.31 ng/mL, respectively (as shown in Figures 7b,d). These cut-off values may serve as potential discriminatory reference points within the present study population, but should not be interpreted as universal diagnostic thresholds. Consequently, in clinical settings, a serum 25(OH)D level below 22.55 ng/mL may be employed as an indicator for diagnosing sepsis. Furthermore, when the 25(OH)D level is below 14.31 ng/mL, in conjunction with other diagnostic criteria, it may be inferred that a patient with sepsis is also suffering from sarcopenia.

These findings underscore the utility of 25(OH)D as a potential biomarker reflecting the nutritional and inflammatory status of patients with sepsis, particularly those with sarcopenia.

Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results

Conclusion

Malnutrition and inflammation were common in patients with sepsis and appeared to be more pronounced in those with concomitant sarcopenia. Serum 25(OH)D levels were associated with nutritional status and inflammatory markers in patients with sepsis, particularly in those with sarcopenia, suggesting that 25(OH)D may serve as a potential biomarker reflecting these clinical features. However, because of the single-center cross-sectional design and limited sample size, these findings should be interpreted with caution. Larger multicenter prospective studies are needed to validate these associations and to further determine the clinical relevance of vitamin D in this population.

Source: Conclusion
Authors’ abstract

Background

Sepsis, a critical infectious syndrome, frequently presents with sarcopenia and is typified by an inflammatory cascade and vitamin D (VD) deficiency. The interrelation between these conditions remains to be fully elucidated. VD, known for its immunomodulatory properties, is suspected to play a role in the pathogenesis of both sepsis and sarcopenia. The significance of serum VD levels in diagnosing sepsis and sarcopenia is well-recognized. This study was designed to scrutinize the relationships among VD, nutritional status, and inflammatory profiles in individuals with sepsis and concurrent sarcopenia, and to explore potential VD cut-off values.

Methods

The study cohort comprised two principal groups: a sepsis group and a control group. The sepsis group was further bifurcated into those with and without sarcopenia. The study enrolled 100 patients diagnosed with sepsis from February 2022 to February 2023, and 92 healthy controls. Of the sepsis patients, 46 had comorbid sarcopenia. Serum 25(OH)D levels, along with nutritional and inflammatory biomarkers, were assessed, and receiver operating characteristic (ROC) curve analysis was performed to determine the optimal cut-off values.

Results

Notable disparities in 25(OH)D levels and markers of nutrition and inflammation were observed between the sepsis and control groups, as well as between the subgroups with and without sarcopenia. The optimal cut-off values of serum 25(OH)D derived from ROC analysis were 22.55 ng/mL for sepsis and 14.31 ng/mL for sepsis with sarcopenia.

Conclusion

Serum 25(OH)D levels were significantly associated with nutritional status and inflammatory responses in patients with sepsis, particularly in those with sarcopenia, and may serve as a potential biomarker reflecting these clinical features.

Read the full paper

Highlights

  • This investigation provides a nuanced understanding of the relationship between VD deficiency, sarcopenia, and sepsis, accentuating the significance of VD in immune modulation.

  • It reveals pronounced differences in serum 25(OH)D levels and related inflammatory and nutritional indicators among sepsis patients, with and without sarcopenia, in contrast to control subjects.

  • The study delineates superior VD threshold criteria for sepsis and its concomitant sarcopenia, highlighting the clinical relevance of VD measurements in the diagnosis and morbidity forecasting for these patient groups.

1

Introduction

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, characterized by complex immune dysfunction and inflammatory responses (1, 2). In addition to systemic inflammation, sepsis is also accompanied by profound metabolic disturbances and immune imbalance, both of which may influence clinical outcomes (1). The pathogenesis of this condition is multifaceted and not yet fully understood. In recent years, the potential role of vitamin D (VD) in the pathogenesis of sepsis has garnered significant interest.

Evidence suggests that VD exerts its influence not only on immune cells but also on a variety of cellular types pivotal to bone and mineral metabolism (3, 4). The regulatory function of VD in modulating immune responses and combating infection is well-documented, and its interplay with inflammatory pathways is a subject of extensive research (5Not reported7). Although the precise mechanisms remain incompletely understood, growing evidence suggests that vitamin D may influence sepsis-related immune and inflammatory responses through modulation of innate and adaptive immunity, cytokine production, and antimicrobial defense.

In observational studies, low serum 25-hydroxyvitamin D (25[OH]D) levels have been associated with a higher risk and greater severity of sepsis, as well as with increased inflammatory burden (8Not reported10).

Since the 1980s, a high prevalence of sarcopenia: characterized by progressive muscle mass and function decline: has been reported among the elderly (11). Sarcopenia is intricately linked to age-related physiological alterations, malnutrition, chronic illnesses, inflammation, and lifestyle factors (12). Emerging research suggests that VD deficiency may be associated with the development and progression of sarcopenia, with low VD levels implicated not only in bone metabolism but also in skeletal muscle physiology. VD may affect muscle health through multiple pathways, including muscle protein synthesis, mitochondrial function, calcium homeostasis, and the modulation of inflammatory signaling.

Furthermore, its regulatory impact on immune function and inflammatory responses may also contribute to the development of sarcopen (13).

Recent investigations have suggested a link between sarcopenia and the onset and severity of sepsis (14, 15). Patients with sepsis often exhibit immune dysregulation, pronounced inflammatory responses, catabolic stress, reduced mobility, and nutritional insufficiency, all of which may contribute to accelerated muscle loss and the development of sarcopenia (16, 17). Conversely, those with sarcopenia are at an increased risk of malnutrition and immune dysfunction at sepsis onset, potentially related to VD’s role in immune modulation and nutrient metabolism (18).

Collectively, these findings suggest that VD deficiency may be associated with both sepsis and sarcopenia, possibly through shared pathways involving immune dysregulation, inflammation, and altered muscle metabolism (19, 20). While the exact role of VD in sepsis and sarcopenia requires further investigation, current evidence supports a potential link between VD status, immune responses, and nutritional/metabolic disturbances in these conditions (21).

The potential clinical relevance of VD deficiency in sepsis and sarcopenia has attracted increasing attention (22, 23). Systematic reviews and meta-analyses have supported an association between VD deficiency and both sepsis and sarcopenia, although these findings are largely based on observational evidence (24, 25). Although several studies have explored the potential role of VD as a biomarker, data on clinically relevant 25(OH)D thresholds in patients with sepsis, particularly those with sarcopenia, remain limited (26Not reported30).

The current study aimed to address this gap by exploring 25(OH)D cut-off values with potential discriminatory value for sepsis and sepsis with sarcopenia, particularly in a Chinese patient population where relevant data remain scarce.

Given the reported associations of VD with nutritional status and inflammation, serum 25(OH)D may have potential value as a biomarker reflecting nutritional and inflammatory status in patients with sepsis and comorbid sarcopenia. Therefore, this study evaluated VD levels in relation to nutritional status and inflammatory markers and further explored their potential discriminatory value by estimating 25(OH)D cut-off values.

2

Materials and methods

2.1

Ethics statement

The study was dutifully approved by the Ethics Committee of the Affiliated Hospital of Guilin Medical University (2022QTLL-45), with the clinical trial registered under the identifier ChiCTR2200060595.1 In strict adherence to the Helsinki Declaration, written informed consent was obtained from all participants prior to study enrollment. All personnel involved in the study underwent rigorous training to ensure standardization of laboratory techniques and procedural uniformity.

2.2

Patients

This was a single-center cross-sectional study conducted in the Department of Emergency Medicine of the Affiliated Hospital of Guilin Medical University. A total of 100 patients with sepsis were enrolled, including 46 patients with concomitant sarcopenia. Participants were consecutively recruited between February 2022 and February 2023 before the initiation of treatment. Eligible sepsis patients were consecutively screened and recruited in the Department of Emergency Medicine during the study period, and healthy controls were recruited during the same period as the comparative group.

The sample size was determined by the number of eligible participants who were consecutively recruited during the study period.

The inclusion criteria for the sepsis group were consecutive patients admitted during the study period who met the Sepsis-3 diagnostic criteria and had not initiated treatment at the time of enrollment. The exclusion criteria were incomplete clinical or laboratory data and inability to provide informed consent. Healthy controls were recruited during the same period and had no evidence of acute infection or sepsis at enrollment. The sepsis diagnosis was ascertained through a synthesis of clinical assessments, biochemical analyses, bacteriological examinations, and histological evaluations, in strict accordance with the Sepsis-3 criteria established in 2016.

For the detection of sarcopenia in the sepsis cohort, a multifaceted approach was employed, integrating clinical presentations, thorough physical examinations, diagnostic imaging, and the authoritative guidelines provided by the Asian Working Group on Sarcopenia (AWGS) as outlined in their 2019 Consensus on the Diagnosis and Treatment of Sarcopenia. Specifically, the diagnosis was based on objective assessments of muscle mass, muscle strength, and physical performance in accordance with the AWGS 2019 criteria. Concurrently, a control group comprising 92 healthy volunteers was assembled to serve as a comparative reference in the study.

2.3

Measurements

Sarcopenia-related assessments included the evaluation of muscle mass, muscle strength, and physical performance according to the AWGS 2019 criteria. Nutritional status was assessed using the Nutritional Risk Screening 2002 (NRS-2002), the Scored Patient-Generated Subjective Global Assessment (PG-SGA), and Body Mass Index (BMI). These tools were used to comprehensively evaluate nutritional risk and nutritional status in the study participants. The NRS-2002 was used to screen for nutritional risk, and a score of ≥3 was considered indicative of nutritional risk. The PG-SGA was used to evaluate nutritional status, and a score of ≥4 was considered indicative of malnutrition.

Anthropometric measurements, height and weight, were recorded with precision to the nearest 0.1 cm and 0.1 kg, respectively, using standardized scales while participants were barefoot and unclothed save for light attire. BMI was calculated using the formula weight in kilograms divided by the square of height in meters. The classification of BMI was as follows: underweight (BMI < 18.5 kg/m2), normal weight (18.5 kg/m2 ≤ BMI < 25 kg/m2), overweight (25 kg/m2 ≤ BMI < 30 kg/m2), and obese (BMI ≥ 30 kg/m2), with underweight being indicative of a nutritional deficiency.

Furthermore, we utilized the Sequential Organ Failure Score (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II), and the Nutritional Risk Score for the Critically Ill Patient (NUTRIC), along with metrics for the incidence of septic shock and the 28-day survival rate, to gauge the inflammatory response and the severity of sepsis. The SOFA score quantified the extent of organ dysfunction, with higher scores correlating with increased infection severity and organ failure. The APACHE II score evaluated the overall disease severity, with higher scores foretelling graver conditions and a more adverse prognosis.

The NUTRIC score assessed the nutritional risk and concurrent disease severity in critically ill patients, with higher scores reflecting greater nutritional risk and more intense disease manifestations.

Laboratory data encompassed measurements of Total Protein (TP), Albumin (ALB), C-reactive protein (CRP), Procalcitonin (PCT), Interleukin-6 (IL-6), and serum 25-hydroxyvitamin D (25[OH]D). CRP and IL-6 were quantified using the Enzyme-Linked Immunosorbent Assay (ELISA), Serum 25(OH)D levels were measured by radioimmunoassay using a DiaSorin analyzer (DiaSorin, Stillwater, MN, USA), PCT levels were determined by chemiluminescence, and TP and ALB were measured using standard biochemical methods. Data collection was uniformly conducted in the morning following an 8: to 12-h fasting period, with each participant assessed by the same researcher to ensure consistency.

Blood samples were systematically collected in 5 mL anticoagulant-free sodium heparin tubes and anticoagulant-free tubes. A qualified physician was responsible for the routine collection of medical history and the assessment of nutritional and inflammatory biomarkers.

2.4

Statistical analysis

Statistical analysis was performed utilizing SPSS version 26.0 (IBM Corp., Armonk, NY, USA). We employed descriptive statistical measures to delineate the demographic and clinical characteristics of the study sample. Quantitative variables were summarized as means and standard deviations, and categorical variables were presented as numbers and percentages. Comparative analyses of indicators between groups were executed using Student’s t-test for variables exhibiting normal distribution, while the Mann: Whitney U test was applied for variables that did not adhere to normal distribution.

Categorical variables were compared using the chi-square test or Fisher’s exact test, as appropriate. The assessment of correlations between various indicators was conducted through linear regression for continuous variables and binary logistic regression analysis for categorical outcomes. Statistical significance was set at the p-value threshold of less than 0.05.

Graphical representations of the data were crafted using GraphPad Prism software, version 8.0.2 (GraphPad Software, San Diego, CA, USA). A receiver operating characteristic (ROC) analysis was implemented to evaluate the diagnostic sensitivity and specificity of serum 25-hydroxyvitamin D (25[OH]D) levels in distinguishing sepsis and sepsis with sarcopenia. This analysis also served to identify the optimal cut-off value for vitamin D levels and to explore their potential discriminatory value.

3

Results

Upon examination of the data presented in Figure 1. The detailed underlying data are provided in Table 1, several notable clinical distinctions emerged between sepsis patients and the control group. The average age of individuals in the sepsis cohort, at 68.630 ± 14.263 years, was marginally elevated in comparison to the control group’s average of 65.577 ± 5.916 years; however, this variance did not reach a level of statistical significance (p = 0.066).

Figure 1

Demographic and clinical characteristics of sepsis and control patients.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Demographic and clinical characteristics of sepsis and control patients.

CharacteristicSepsisControl P
N (male/female)100 (65/35)92 (62/30)Not reported
Age (years)68.630 ± 14.26365.577 ± 5.9160.066
NRS-20023.410 ± 1.4780.120 ± 0.435<0.001
PG-SGA7.920 ± 5.5131.308 ± 3.723<0.001
BMI (kg/m2)20.614 ± 5.16124.458 ± 3.585<0.001
TP (g/L)69.297 ± 8.38271.589 ± 4.6380.032
ALB (g/L)36.302 ± 6.42941.741 ± 2.456<0.001
CRP (mg/L)48.306 ± 53.5822.834 ± 8.474<0.001
PCT (ng/mL)6.152 ± 20.9280.119 ± 0.1750.005
IL-6 (pg/mL)80.358 ± 208.4782.662 ± 2.392<0.001
Serum 25(OH)D (ng/mL)18.002 ± 8.62924.822 ± 9.6630.007

Data are mean values ± standard deviation (SD). NRS-2002: Nutrition Risk Screening 2002; PG-SGA score: Patient-Generated Subjective Global Assessment score; BMI: Body Mass Index; TP: Total Protein; ALB: Albumin; CRP: C-reactive protein; PCT: Procalcitonin; IL-6: Interleukin 6. p-values were calculated using Student’s t-test for normally distributed variables or Mann: Whitney U test for those not normally distributed. Differences were considered significant at p < 0.05.

Significant disparities were observed in the NRS-2002 and PG-SGA scores, with the sepsis group consistently demonstrating higher scores: 3.410 ± 1.478 versus 0.120 ± 0.435 (p < 0.001) for NRS-2002, and 7.920 ± 5.513 versus 1.308 ± 3.723 (p < 0.001) for PG-SGA, respectively. Additionally, the body mass index (BMI) of the sepsis group was markedly reduced compared to the control group, with respective averages of 20.614 ± 5.161 and 24.458 ± 3.585 (p < 0.001), indicating a pronounced malnutrition profile.

Biochemical indices further delineated the divergence between the two groups. The sepsis group exhibited significantly diminished levels of TP and ALB, with averages of 69.297 ± 8.382 and 36.302 ± 6.429, contrasting with the control group’s 71.589 ± 4.638 and 41.741 ± 2.456 (p = 0.032 for TP, p < 0.001 for ALB). Conversely, the sepsis group displayed elevated levels of CRP, PCT, and IL-6: 48.306 ± 53.582 versus 2.834 ± 8.474 (p < 0.001) for CRP, 6.152 ± 20.928 versus 0.119 ± 0.175 (p = 0.005) for PCT, and 80.358 ± 208.478 versus 2.662 ± 2.392 (p < 0.001) for IL-6.

Furthermore, serum 25(OH)D levels were significantly depressed in the sepsis group, with an average of 18.002 ± 8.629 compared to the control group’s 24.822 ± 9.663 (p = 0.007).

In essence, the clinical and biochemical profiles of sepsis patients reveal a starkly malnourished and inflammatory phenotype, which may be intricately connected to the etiology and clinical progression of sepsis.

The data were analyzed to discern the impact of sarcopenia on sepsis patients, with the sepsis cohort stratified into those with and without sarcopenia for a comparative study. As delineated in Figure 2. The detailed underlying data are provided in Table 2, substantial disparities were noted between these two subgroups within the sepsis population.

Figure 2

Demographic and clinical characteristics of patients with sepsis.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 2

Demographic and clinical characteristics of patients with sepsis.

CharacteristicSepsis with sarcopeniaSepsis without sarcopenia p
N (male/female)46 (32/14)54 (35/19)Not reported
Age (years)73.500 ± 10.67264.481 ± 15.584<0.001
NRS-20024.391 ± 1.2732.574 ± 1.070<0.001
PG-SGA9.783 ± 5.5816.333 ± 4.9520.001
BMI (kg/m2)16.139 ± 2.16724.426 ± 3.668<0.001
SOFA3.913 ± 2.3173.130 ± 1.6410.041
APACHE II14.022 ± 6.07210.333 ± 5.1520.001
NUTRIC2.696 ± 1.8241.852 ± 1.3450.006
The incidence rate of septic shock (%)15.217 (7/46)1.852 (1/54)0.003
28-day survival rate (%)67.391 (31/46)94.444 (51/54)<0.001
TP (g/L)67.462 ± 9.38370.860 ± 7.1140.031
ALB (g/L)34.538 ± 6.43237.804 ± 6.0620.004
CRP (mg/L)60.147 ± 51.40738.439 ± 53.5680.021
PCT (ng/mL)12.284 ± 30.1571.157 ± 2.6540.019
IL-6 (pg/mL)131.084 ± 296.87937.289 ± 48.5540.041
Serum 25(OH)D (ng/mL)15.222 ± 7.05420.559 ± 9.159<0.001

Data are presented as mean ± standard deviation (SD). NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6. Statistical significance was determined using Student’s t-test for normally distributed variables or Mann: Whitney U test for non-normally distributed variables, with differences considered significant at p < 0.05.

The mean age of the sepsis group complicated by sarcopenia (73.500 ± 10.672 years) was notably elevated compared to the sepsis group without sarcopenia (64.481 ± 15.584 years), with this difference attaining statistical significance (p < 0.001). The sepsis group with sarcopenia also exhibited markedly higher scores in the NRS-2002 and PG-SGA assessments, with respective values of 4.391 ± 1.273 versus 2.574 ± 1.070 (p < 0.001) and 9.783 ± 5.581 versus 6.333 ± 4.952 (p = 0.001).

Furthermore, this group demonstrated a significantly reduced BMI (16.139 ± 2.167 vs. 24.426 ± 3.668, p < 0.001), underscoring a pronounced malnutrition phenotype.

Clinical scoring systems indicated a trend towards higher severity in the sepsis group with sarcopenia, as evidenced by the SOFA score (3.913 ± 2.317 vs. 3.130 ± 1.641, p = 0.041) and APACHE II score (14.022 ± 6.072 vs. 10.333 ± 5.152, p = 0.001). Similarly, the NUTRIC score was modestly elevated in the sepsis group with sarcopenia (2.696 ± 1.824 vs. 1.852 ± 1.345, p = 0.006). Clinical outcome parameters included the incidence of septic shock and the 28-day survival rate.

The rate of septic shock was significantly more prevalent in the sepsis group with sarcopenia (15.217% vs. 1.852%, p = 0.003), while the 28-day survival rate was considerably lower in this group (67.391% vs. 94.444%, p < 0.001), indicating a poorer prognosis.

Biochemical parameters revealed that levels of TP and ALB were significantly lower, whereas CRP, PCT, and IL-6 were significantly higher in the sepsis group with sarcopenia compared to the non-sarcopenia group, with respective values of 67.462 ± 9.383 vs. 70.860 ± 7.114 (p = 0.031), 34.538 ± 6.432 vs. 37.804 ± 6.062 (p = 0.004), 60.147 ± 51.407 vs. 38.439 ± 53.568 (p = 0.021), 12.284 ± 30.157 vs. 1.157 ± 2.654 (p = 0.019), and 131.084 ± 296.879 vs. 37.289 ± 48.554 (p = 0.041).

Additionally, serum 25(OH)D levels were significantly reduced in the sepsis group with sarcopenia (15.222 ± 7.054 vs. 20.559 ± 9.159, p < 0.001).

In summary, sepsis patients with concomitant sarcopenia displayed significant malnutrition, a robust inflammatory response, and a higher incidence of septic shock coupled with a diminished survival rate. These clinical features and biochemical indices suggest a strong correlation between sarcopenia and adverse outcomes in sepsis.

The regression analyses elucidating the relationships between serum 25(OH)D levels and various indices are show in Figure 3, The detailed underlying data are provided in Table 3. This table encapsulates the findings from regression models assessing the association of serum 25(OH)D with nutritional and inflammatory markers across different groups: sepsis patients, those with sepsis and sarcopenia, those with sepsis without sarcopenia, and a control cohort. In the sepsis group, serum 25(OH)D exhibited a significant negative correlation with the NRS-2002, PG-SGA, SOFA, APACHE II, and NNUTRIC scores.

Conversely, it demonstrated a positive correlation with BMI, TP, and ALB.

Figure 3

Regression analysis between serum 25(OH)D and nutritional, inflammatory indicators for total sepsis, sepsis with sarcopenia, sepsis without sarcopenia and control groups.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 3

Regression analysis between serum 25(OH)D and nutritional, inflammatory indicators for total sepsis, sepsis with sarcopenia, sepsis without sarcopenia and control groups.

CharacteristicSepsisSepsis with sarcopeniaSepsis without sarcopeniaControl
β p β p β p β p
NRS-2002−0.381<0.001−0.3490.017−0.2570.010−0.1150.567
PG-SGA−0.694<0.001−0.882<0.001−0.599<0.0010.1250.512
BMI (kg/m2)0.2210.0070.3820.009−0.0630.531−0.0500.793
SOFA−0.2530.002−0.508<0.001−0.0840.404Not reportedNot reported
APACHE II−0.314<0.001−0.4220.004−0.1760.080Not reportedNot reported
NUTRIC−0.319<0.001−0.519<0.001−0.1560.122Not reportedNot reported
TP (g/L)0.1680.0420.3640.0130.0140.894−0.0720.722
ALB (g/L)0.377<0.0010.501<0.0010.2840.0040.1630.416
CRP (mg/L)−0.480<0.001−0.3800.010−0.486<0.001−0.4790.012
PCT (ng/mL)−0.2700.001−0.4650.0010.0840.4070.4950.005
IL-6 (pg/mL)−0.307<0.001−0.4060.006−0.3330.001−0.604<0.001

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Among the sepsis patients with sarcopenia, the negative correlation between serum 25(OH)D and inflammatory markers was more pronounced, with correlation coefficients of β = −0.380 for CRP (p = 0.010), β = −0.465 for PCT (p = 0.001), and β = −0.406 for IL-6 (p = 0.006), indicating a stronger relationship with inflammatory burden. In contrast, in the sepsis group without sarcopenia, serum 25(OH)D was also negatively correlated with CRP (β = −0.486, p < 0.001) and IL-6 (β = −0.333, p = 0.001), whereas the association with PCT was not statistically significant (β = 0.084, p = 0.407).

In the control group, serum 25(OH)D levels were negatively associated with the NRS-2002, PG-SGA, CRP, and IL-6, while a positive association was observed with BMI, TP, ALB, and PCT.

These regression analyses underscore a discernible link between serum 25(OH)D levels and the nutritional and inflammatory profiles of sepsis patients, particularly within the subgroup presenting with both sepsis and sarcopenia. The findings hint at the potential role of vitamin D in modulating the inflammatory and nutritional dynamics in critical illness.

The regression analyses, with the key results visualized in Figures 4 and 5 and the full statistical details provided in Tables 4 and 5, yield several key insights into the interplay between nutritional and inflammatory markers within the sepsis population. In the sepsis group, a correlation was identified between nutritional indicators: encompassing the NRS-2002, PG-SGA, BMI, TP, and ALB: and inflammatory markers, which included the SOFA, APACHE II, NUTRIC, CRP, PCT, and IL-6.

Figure 4

Regression analysis between nutrition indicators and inflammatory markers in sepsis group.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 5

Regression analysis between nutrition indicators and inflammatory markers in sepsis with sarcopenia group.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 4

Regression analysis between nutrition indicators and inflammatory markers in sepsis group.

CharacteristicNRS-2002PG-SGABMI (kg/m2)TP (g/L)ALB (g/L)
β p β p β p β p β p
SOFA0.335<0.0010.2640.001−0.2360.003−0.498<0.001−0.428<0.001
APACHE II0.5430.0060.282<0.001−0.296<0.001−0.383<0.001−0.316<0.001
NUTRIC0.463<0.0010.301<0.001−0.2680.001−0.367<0.001−0.327<0.001
CRP (mg/L)0.332<0.0010.400<0.001−0.1120.167−0.2370.003−0.377<0.001
PCT (ng/mL)0.491<0.0010.397<0.001−0.378<0.001−0.484<0.001−0.384<0.001
IL-6 (pg/mL)0.397<0.0010.381<0.001−0.289<0.001−0.444<0.001−0.364<0.001

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Table 5

Regression analysis between nutrition indicators and inflammatory markers in sepsis with sarcopenia group.

CharacteristicNRS-2002PG-SGABMI (kg/m2)TP (g/L)ALB (g/L)
β p β p β p β p β p
SOFA0.4710.0010.548<0.001−0.4840.001−0.671<0.001−0.504<0.001
APACHE II0.545<0.0010.506<0.001−0.4350.003−0.598<0.001−0.3280.026
NUTRIC0.531<0.0010.546<0.001−0.3450.019−0.530<0.001−0.3280.026
CRP (mg/L)0.4800.0010.4580.002−0.548<0.001−0.631<0.001−0.4870.001
PCT (ng/mL)0.607<0.0010.610<0.001−0.644<0.001−0.674<0.001−0.545<0.001
IL-6 (pg/mL)0.4650.0010.4770.001−0.576<0.001−0.697<0.001−0.565<0.001

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Notably, the NRS-2002, PG-SGA, and BMI scores were found to be positively correlated with the SOFA, APACHE II, and NUTRIC scores, while an inverse relationship was observed with CRP, PCT, and IL-6 levels. This inverse correlation implies that an enhanced nutritional status may correlate with reduced inflammatory activity. Within the subgroup of sepsis patients with sarcopenia, these associations were even more pronounced, indicating that the presence of malnutrition and sarcopenia could be linked to heightened inflammation and a greater risk of organ dysfunction.

The findings from these analyses underscore the intricate relationship between a patient’s nutritional status and systemic inflammation, and they highlight the significance of considering both nutritional and inflammatory parameters in the comprehensive care of sepsis patients. This holistic approach may facilitate more effective treatment strategies and improved patient outcomes.

In the binary logistic regression analysis, the sepsis cohort was bifurcated into two distinct groups based on the presence or absence of sarcopenia, with these groups serving as the dependent variables. The outcomes of this analysis are delineated in Figure 6, The detailed underlying data are provided in Table 6. Serum 25(OH)D levels were significantly associated with sepsis classification in the binary logistic regression model (β = 0.085, OR = 1.089, 95% CI: 1.034 to 1.147, p = 0.001).

The OR was calculated to be 1.089, with a 95% CI ranging from 1.034 to 1.147, indicating that for every unit increase in serum 25(OH)D, there is an 8.9% increase in the odds of a favorable outcome.

Figure 6

Binary logistic regression model addressing the associations between Serum 25(OH)D, nutrition indicators, infection markers and sepsis classification.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 6

Binary logistic regression model addressing the associations between serum 25(OH)D, nutrition indicators, infection markers and sepsis classification.

Characteristic β p ORCI (95%)
Serum 25(OH)D (ng/mL)0.0850.0011.0891.034 to 1.147
NRS-2002−1.103<0.0010.3320.233 to 0.474
PG-SGA−0.1210.0010.8860.826 to 0.950
BMI (kg/m2)1.601<0.0014.9572.448 to 10.040
SOFA−0.2050.0260.8140.680 to 0.975
APACHE II−0.1170.0010.8900.833 to 0.951
NUTRIC−0.3390.0030.7120.569 to 0.892
TP (g/L)0.0550.0181.0561.009 to 1.105
ALB (g/L)0.0860.0041.0901.027 to 1.157
CRP (mg/L)−0.0070.0250.9930.987 to 0.999
PCT (ng/mL)−0.0490.0360.9520.909 to 0.997
IL-6 (pg/mL)−0.0070.0060.9940.989 to 0.998

NRS-2002, Nutrition Risk Screening 2002; PG-SGA score, Patient-Generated Subjective Global Assessment score; BMI, Body Mass Index; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; NUTRIC, Nutrition Risk in Critically Ill; TP, Total Protein; ALB, Albumin; CRP, C-reactive protein; PCT, Procalcitonin; IL-6, Interleukin 6.

Furthermore, nutritional indicators demonstrated a negative correlation with the severity of inflammation, with this association reaching statistical significance (p < 0.05). This suggests that improved nutritional status is inversely related to inflammatory severity, reinforcing the potential mitigating role of adequate nutrition in modulating the inflammatory response in sepsis.

The ROC curve analyses, along with the determination of optimal cut-off values, are illustrated in Figure 7. Notably, significant differences in serum 25(OH)D levels were observed when comparing the sepsis and control groups, as well as between the sepsis with sarcopenia and the sepsis without sarcopenia groups (as depicted in Figures 7a,c). For the sepsis versus control group comparison, the AUC was calculated to be 0.7021, indicating that 25(OH)D demonstrated a sensitivity of 70.0% and a specificity of 72.9%, indicating a moderate discriminatory performance.

In contrast, the AUC for distinguishing the sepsis-combined-sarcopenia group from the non-sarcopenia group was 0.6780, with a sensitivity of 72.0% and a specificity of 56.5%, suggesting a modest discriminatory value.

Figure 7

Analysis of 25(OH)D cut-off values for diagnosing Sepsis. Means and p-values of serum 25(OH)D levels in the sepsis and control groups (a), and the sepsis with Sarcopenia and without Sarcopenia groups (c). The ROC analysis to determine optimal cut-off values in the sepsis and control groups (b), and the sepsis with sarcopenia and without sarcopenia groups (d). ROC, receiver operating characteristic.

Figure image at the original source: open the original paper. This file is not included in this text import.

The optimal cut-off values for 25(OH)D, showing the best discriminatory performance for distinguishing sepsis and sepsis with sarcopenia, were identified as 22.55 ng/mL and 14.31 ng/mL, respectively (as shown in Figures 7b,d). These cut-off values may serve as potential discriminatory reference points within the present study population, but should not be interpreted as universal diagnostic thresholds. Consequently, in clinical settings, a serum 25(OH)D level below 22.55 ng/mL may be employed as an indicator for diagnosing sepsis. Furthermore, when the 25(OH)D level is below 14.31 ng/mL, in conjunction with other diagnostic criteria, it may be inferred that a patient with sepsis is also suffering from sarcopenia.

These findings underscore the utility of 25(OH)D as a potential biomarker reflecting the nutritional and inflammatory status of patients with sepsis, particularly those with sarcopenia.

4

Discussion

In the current investigation, a high prevalence of severe malnutrition and inflammatory conditions was noted among patients with sepsis, corroborating previous studies (31Not reported33). The ubiquity of malnutrition in this patient population is underscored by diminished BMI and reduced levels of TP and ALB (34Not reported36). Concurrently, pronounced inflammatory responses are indicated by increased serum concentrations of CRP, PCT and IL-6 (37Not reported41). These observations are in line with existing literature that recognizes inflammation and malnutrition as prevalent clinical manifestations in sepsis, suggesting their integral roles in the pathophysiology of the condition and their potential influence on the evolution and severity of sepsis (42, 43).

This study further revealed that the sepsis cohort with comorbid sarcopenia exhibited exacerbated malnutrition and more adverse clinical outcomes. Patients in this subgroup were characterized by an elevated mean age, higher nutritional scores as measured by the NRS-2002 and PG-SGA, and a decreased BMI. These findings imply a close relationship between malnutrition and the development and exacerbation of sarcopenia in sepsis patients. Prior research has also established a higher incidence of malnutrition in sarcopenic patients, with nutritional status being intricately linked to sarcopenia severity (11, 44).

These findings underscore the importance of nutritional and muscle-related assessments in patients with sepsis, particularly in those with sarcopenia. However, given the cross-sectional design of the present study, the observed associations should not be interpreted as evidence of causality or as proof of intervention efficacy.

Serum 25(OH)D levels were identified as a significant parameter in this study, with sepsis patients showing significantly lower levels compared to controls. A negative correlation was observed between 25(OH)D levels and the onset and progression of sepsis. Notably, the subgroup of patients with sepsis and myasthenia gravis presented with even lower 25(OH)D levels, aligning with previous findings that have reported reduced levels in sepsis (7, 45Not reported47) and myasthenia gravis (10, 48Not reported50) patients.

These data hint at a pivotal role for 25(OH)D in the pathogenesis of sepsis, with its deficiency potentially contributing to malnutrition and sarcopenia in affected patients.

Nutritional support remains an important component of sepsis care, and previous studies have explored its possible relationship with clinical outcomes (51Not reported55). However, the present study did not evaluate the effects of vitamin D supplementation or nutritional intervention. Therefore, our findings should be interpreted as observational associations only, and the potential benefits of these interventions in patients with sepsis and sarcopenia require confirmation in prospective interventional studies.

This study has several limitations. First, it was conducted at a single center, and the study population was derived from one hospital, which may limit the generalizability of the findings to other regions, healthcare settings, or patient populations. Second, the sample size was relatively limited, particularly for subgroup analyses, which may reduce the robustness of the statistical analyses and increase the possibility of random error or type II error. Third, because this was a cross-sectional study, the observed associations between serum 25(OH)D levels and nutritional or inflammatory indicators should be interpreted as correlations rather than causal relationships.

In addition, potential confounding factors affecting serum 25(OH)D levels, such as sunlight exposure, previous vitamin D supplementation, seasonal variation, and metabolic comorbidities, were not systematically collected or controlled for in the present study. Finally, dynamic changes in vitamin D status and the effects of interventions were not evaluated. Therefore, larger multicenter prospective studies are needed to validate the present findings and further clarify the clinical relevance of vitamin D in patients with sepsis and sarcopenia.

5

Conclusion

Malnutrition and inflammation were common in patients with sepsis and appeared to be more pronounced in those with concomitant sarcopenia. Serum 25(OH)D levels were associated with nutritional status and inflammatory markers in patients with sepsis, particularly in those with sarcopenia, suggesting that 25(OH)D may serve as a potential biomarker reflecting these clinical features. However, because of the single-center cross-sectional design and limited sample size, these findings should be interpreted with caution. Larger multicenter prospective studies are needed to validate these associations and to further determine the clinical relevance of vitamin D in this population.

Acknowledgments

Our sincere gratitude is extended to the study volunteers, hospital staff, and laboratory personnel for their invaluable assistance and support throughout the conduct of the research. We especially thank Ruchun Jia from Sichuan Leading Pilot Tech Co., Ltd. for providing technical support in data analysis and statistics.

Edited by: Selvaraj Anthonymuthu, University of California, Irvine, United States

Reviewed by: Seema Mudhol, Sri Adichunchanagiri College of Pharmacy, India

Silvio Pires Gomes, University of São Paulo, Brazil

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving humans were approved by The First Affiliated Hospital of Guilin Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

HZ: Conceptualization, Data curation, Writing: original draft, Formal analysis, Methodology. CB: Data curation, Methodology, Resources, Writing: review & editing, Funding acquisition. ZM: Project administration, Supervision, Validation, Visualization, Writing: original draft, Writing: review & editing. BW: Data curation, Funding acquisition, Investigation, Software, Supervision, Writing: original draft, Writing: review & editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that Generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Cutuli SL Ferrando ES Cammarota F Franchini E Caroli A Lombardi G . Update on vitamin D role in severe infections and sepsis . J Anesth Analg Crit Care . (2024 ) 4 :4 . doi: 10.1186/s44158-024-00139-5 , 38263252 PMC10804708
2. Darnifayanti D Rizki DR Amirah S Abdurrahman MF Akmal M Abdulmadjid SN . Association between vitamin D receptor gene variants and neonatal sepsis: a systematic review and meta-analysis . J Infect Public Health . (2024 ) 17 :518Not reported26 . doi: 10.1016/j.jiph.2024.01.011 , 38306913
3. Seok H Kim J Choi WS Park DW . Effects of vitamin D deficiency on sepsis . Nutrients . (2023 ) 15 :4309 . doi: 10.3390/nu15204309 , 37892385 PMC10609566
4. Li Q Li W Chen M Chai Y Guan L Chen Y . Association of vitamin D receptor gene polymorphism with the risk of sepsis: a systematic review and meta-analysis . Medicine . (2023 ) 102 :e35130 . doi: 10.1097/MD.0000000000035130 , 37746941 PMC10519506
5. Workneh Bitew Z Worku T Alemu A . Effects of vitamin D on neonatal sepsis: a systematic review and meta-analysis . Food Sci Nutr . (2021 ) 9 :375Not reported88 . doi: 10.1002/fsn3.2003 , 33473300 PMC7802542
6. Guan J Shichen M Liang Z Yu S Zhao M Zhang L . Potential benefits of vitamin D for sepsis prophylaxis in critical ill patients . Front Nutr . (2023 ) 10 :1073894 . doi: 10.3389/fnut.2023.1073894 , 37081919 PMC10110989
7. Su G Jia D . Vitamin D in acute and critically sick children with a subgroup of sepsis and mortality: a meta-analysis . Nutr Cancer . (2021 ) 73 :1118Not reported25 . doi: 10.1080/01635581.2020.1784964 , 32597305
8. Vanichkulbodee A Romposra M Inboriboon PC Trongtrakul K . Effects of vitamin D insufficiency on sepsis severity and risk of hospitalisation in emergency department patients: a cross-sectional study . BMJ Open . (2023 ) 13 :e064985 . doi: 10.1136/bmjopen-2022-064985 , 36653058 PMC9853214
9. Remelli F Vitali A Zurlo A Volpato S . Vitamin D deficiency and sarcopenia in older persons . Nutrients . (2019 ) 11 :2861 . doi: 10.3390/nu11122861 , 31766576 PMC6950416
10. Uchitomi R Oyabu M Kamei Y . Vitamin D and sarcopenia: potential of vitamin D supplementation in sarcopenia prevention and treatment . Nutrients . (2020 ) 12 :3189 . doi: 10.3390/nu12103189 , 33086536 PMC7603112
11. Liu W Hu C Zhao S . Sarcopenia and mortality risk of patients with sepsis: a meta-analysis . Int J Clin Pract . (2022 ) 2022 :4974410 . doi: 10.1155/2022/4974410 , 35685536 PMC9159150
12. Darden N Sharma S Wu X Mancini B Karamchandani K Bonavia AS . Long-term clinical outcomes in critically ill patients with sepsis and pre-existing low muscle mass: a retrospective cohort study . BMC Anesthesiol . (2023 ) 23 :313 . doi: 10.1186/s12871-023-02274-y , 37715183 PMC10503077
13. Ebadi M Montano-Loza AJ . Insights on clinical relevance of sarcopenia in patients with cirrhosis and sepsis . Liver Int . (2018 ) 38 :786Not reported8 . doi: 10.1111/liv.13720 , 29702742
14. Herault A Lévêque E Draye-Carbonnier S Decazes P Zduniak A Modzelewski R . High prevalence of pre-existing sarcopenia in critically ill patients with hematologic malignancies admitted to the intensive care unit for sepsis or septic shock . Clin Nutr ESPEN . (2023 ) 55 :373Not reported83 . doi: 10.1016/j.clnesp.2023.04.007 , 37202070
15. Zanders L Kny M Hahn A Schmidt S Wundersitz S Todiras M . Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting . J Cachexia Sarcopenia Muscle . (2022 ) 13 :713Not reported27 . doi: 10.1002/jcsm.12867 , 34821076 PMC8818599
16. Kim HB Chun SY Kim GW Lim H Cho YS . Can sarcopenia predict poor prognosis of sepsis due to acute cholecystitis? Am J Emerg Med . (2023 ) 73 :69Not reported74 . doi: 10.1016/j.ajem.2023.08.014 , 37619445
17. Cox MC Booth M Ghita G Wang Z Gardner A Hawkins RB . The impact of sarcopenia and acute muscle mass loss on long-term outcomes in critically ill patients with intra-abdominal sepsis . J Cachexia Sarcopenia Muscle . (2021 ) 12 :1203Not reported13 . doi: 10.1002/jcsm.12752 , 34196134 PMC8517344
18. Bollen SE Bass JJ Fujita S Wilkinson D Hewison M Atherton PJ . The vitamin D/vitamin D receptor (VDR) axis in muscle atrophy and sarcopenia . Cell Signal . (2022 ) 96 :110355 . doi: 10.1016/j.cellsig.2022.110355 , 35595176
19. Chang MC Choo YJ . Effects of whey protein, leucine, and vitamin D supplementation in patients with sarcopenia: a systematic review and meta-analysis . Nutrients . (2023 ) 15 :521 . doi: 10.3390/nu15030521 , 36771225 PMC9920795
20. Abiri B Vafa M . “Vitamin D and muscle sarcopenia in aging“. In: Clinical and Preclinical Models for Maximizing Healthspan: Methods and Protocols . Berlin: Springer (2020 ). p. 29Not reported47 . 10.1007/978-1-0716-0471-7_2 32219739
21. Xiao D Zhang X Ying J Zhou Y Li X Mu D . Association between vitamin D status and sepsis in children: a meta-analysis of observational studies . Clin Nutr . (2020 ) 39 :1735Not reported41 . doi: 10.1016/j.clnu.2019.08.010 , 31495735
22. Adeyemi OM Agniel D French AL Tien PC Weber K Glesby MJ . Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States . J Acquir Immune Defic Syndr . (2011 ) 57 :197Not reported204 . doi: 10.1097/QAI.0b013e31821ae418 , 21471818 PMC3431159
23. Prokopidis K Giannos P Katsikas Triantafyllidis K Kechagias KS Mesinovic J Witard OC . Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis . J Cachexia Sarcopenia Muscle . (2022 ) 13 :1642Not reported52 . doi: 10.1002/jcsm.12976 , 35261183 PMC9178168
24. Moon HW Chung HJ Hur M Yun YM . Vitamin D status and thyroid autoimmunity in Korean pregnant women . J Matern Fetal Neonatal Med . (2015 ) 28 :2210Not reported3 . doi: 10.3109/14767058.2014.982530 , 25373429
25. Luo X Liao Q Shen Y Li H Cheng L . Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people . J Nutr . (2021 ) 151 :98Not reported103 . doi: 10.1093/jn/nxaa332 , 33188401 PMC7890671
26. Ismailova A White JH . Vitamin D, infections and immunity . Rev Endocrine Metab Disorders . (2022 ) 23 :265Not reported77 . doi: 10.1007/s11154-021-09679-5 , 34322844 PMC8318777
27. Mercola J Grant WB Wagner CL . Evidence regarding vitamin D and risk of COVID-19 and its severity . Nutrients . (2020 ) 12 :3361 . doi: 10.3390/nu12113361 , 33142828 PMC7692080
28. Cecchi A Bonizzoli M Douar S Mangini M Paladini S Gazzini B . Vitamin D deficiency in septic patients at ICU admission is not a mortality predictor . Minerva Anestesiol . (2011 ) 77 :1184Not reported9 . 21720281
29. Ala-Kokko TI Mutt SJ Nisula S Koskenkari J Liisanantti J Ohtonen P . Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: observational FINNAKI cohort study . Ann Med . (2016 ) 48 :67Not reported75 . doi: 10.3109/07853890.2015.1134807 , 26800186
30. Wang Y Shi C Yang Z Chen F Gao L . Vitamin D deficiency and clinical outcomes related to septic shock in children with critical illness: a systematic review . Eur J Clin Nutr . (2019 ) 73 :1095Not reported101 . doi: 10.1038/s41430-018-0249-0 , 30006615
31. De Waele E Malbrain ML Spapen H . Nutrition in sepsis: a bench-to-bedside review . Nutrients . (2020 ) 12 :395 . doi: 10.3390/nu12020395 , 32024268 PMC7071318
32. Collins K Huen SC . Metabolism and nutrition in sepsis: in need of a paradigm shift . Nephron . (2023 ) 147 :733Not reported6 . doi: 10.1159/000534074 , 37703850 PMC11098033
33. Huwiler VV Scalise M Schönenberger KA Mühlebach S Stanga Z Balmer ML . The role of dietary fibre in enteral nutrition in Sepsis prevention and therapy: a narrative review . Nutrients . (2023 ) 15 :2489 . doi: 10.3390/nu15112489 , 37299452 PMC10255575
34. Cha JK Kim HS Kim EJ Lee ES Lee JH Song IA . Effect of early nutritional support on clinical outcomes of critically ill patients with sepsis and septic shock: a single-center retrospective study . Nutrients . (2022 ) 14 :2318 . doi: 10.3390/nu14112318 , 35684117 PMC9182793
35. Nadamuni M Venable AH Huen SC . When a calorie isn’t just a calorie: a revised look at nutrition in critically ill patients with sepsis and acute kidney injury . Curr Opin Nephrol Hypertens . (2022 ) 31 :358Not reported66 . doi: 10.1097/MNH.0000000000000801 , 35703214 PMC9248034
36. Van Niekerk G Meaker C Engelbrecht AM . Nutritional support in sepsis: when less may be more . Crit Care . (2020 ) 24 :53 . doi: 10.1186/s13054-020-2771-4 , 32059698 PMC7023788
37. Buchman TG Simpson SQ Sciarretta KL Finne KP Sowers N Collier M . Sepsis among medicare beneficiaries: 3. The methods, models, and forecasts of sepsis, 2012 to 2018 . Crit Care Med . (2020 ) 48 :302Not reported18 . doi: 10.1097/CCM.0000000000004225 , 32058368 PMC7017950
38. Rudd KE Johnson SC Agesa KM Shackelford KA Tsoi D Kievlan DR . Global, regional, and national sepsis incidence and mortality, 1990 to 2017: analysis for the global burden of disease study . Lancet . (2020 ) 395 :200Not reported11 . doi: 10.1016/S0140-6736(19)32989-7 , 31954465 PMC6970225
39. Rhee C Jones TM Hamad Y Pande A Varon J O’Brien C . Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals . JAMA Netw Open . (2019 ) 2 :e187571Not reported1 . doi: 10.1001/jamanetworkopen.2018.7571 , 30768188 PMC6484603
40. Lu J Liu J Zhu L Zhang Y Li A . The effect of age on the clinical characteristics and innate immune cell function in the patients with abdominal sepsis . Front Physiol . (2022 ) 13 :952434 . doi: 10.3389/fphys.2022.952434 , 36237524 PMC9551265
41. Gritte RB Souza-Siqueira T Curi R Machado MCC Soriano FG . Why septic patients remain sick after hospital discharge? Front Immunol . (2021 ) 11 :605666 . doi: 10.3389/fimmu.2020.605666 , 33658992 PMC7917203
42. Englert JA Rogers AJ . Metabolism, metabolomics, and nutritional support of patients with sepsis . Clin Chest Med . (2016 ) 37 :321Not reported31 . doi: 10.1016/j.ccm.2016.01.011 , 27229648 PMC5084839
43. Yang XJ Wang XH Yang MY Ren HY Chen H Zhang XY . Exploring choices of early nutritional support for patients with sepsis based on changes in intestinal microecology . World J Gastroenterol . (2023 ) 29 :2034Not reported49 . doi: 10.3748/wjg.v29.i13.2034 , 37155528 PMC10122787
44. Baggerman MR van Dijk DP Winkens B van Gassel RJ Bol ME Schnabel RM . Muscle wasting associated co-morbidities, rather than sarcopenia are risk factors for hospital mortality in critical illness . J Crit Care . (2020 ) 56 :31Not reported6 . doi: 10.1016/j.jcrc.2019.11.016 31805466
45. Li Y Ding S . Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis . BMC Infect Dis . (2020 ) 20 :189 . doi: 10.1186/s12879-020-4879-1 , 32131740 PMC7057612
46. Sarhan N Abou Warda AE Sarhan RM Boshra MS Mostafa-Hedeab G ALruwaili BF . Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: a randomized clinical trial . Medicina (Kaunas) . (2022 ) 58 :1358 . doi: 10.3390/medicina58101358 , 36295519 PMC9609310
47. Chae B Kim YJ Kim SM Hong SI Shin YS Kim JS . Vitamin D deficiency on admission to the emergency department is a mortality predictor for patients with septic shock treated with early protocol-driven resuscitation bundle therapy . Am J Med Sci . (2023 ) 365 :361Not reported7 . doi: 10.1016/j.amjms.2022.10.005 , 36265656
48. Surdu AM Pînzariu O Ciobanu DM Negru AG Căinap SS Lazea C . Vitamin D and its role in the lipid metabolism and the development of atherosclerosis . Biomedicine . (2021 ) 9 :172 . doi: 10.3390/biomedicines9020172 , 33572397 PMC7916166
49. Montenegro KR Carlessi R Cruzat V Newsholme P . Effects of vitamin D on primary human skeletal muscle cell proliferation, differentiation, protein synthesis and bioenergetics . J Steroid Biochem Mol Biol . (2019 ) 193 :105423 . doi: 10.1016/j.jsbmb.2019.105423 , 31279004
50. Montenegro KR Cruzat V Carlessi R Newsholme P . Mechanisms of vitamin D action in skeletal muscle . Nutr Res Rev . (2019 ) 32 :192Not reported204 . doi: 10.1017/S0954422419000064 , 31203824
51. Jeong DH Hong SB Lim CM Koh Y Seo J Kim Y . Relationship between nutrition intake and 28-day mortality using modified NUTRIC score in patients with sepsis . Nutrients . (2019 ) 11 :1906 . doi: 10.3390/nu11081906 , 31443186 PMC6723508
52. McLaughlin J Chowdhury N Djurkovic S Shahab O Sayiner M Fang Y . Clinical outcomes and financial impacts of malnutrition in sepsis . Nutr Health . (2020 ) 26 :175Not reported8 . doi: 10.1177/0260106020930145 , 32571151
53. Adjemian D Arendt BM Allard JP . Assessment of parenteral nutrition prescription in Canadian acute care settings . Nutrition . (2018 ) 49 :7Not reported12 . doi: 10.1016/j.nut.2017.11.023 , 29571609
54. Amrein K Schnedl C Holl A Riedl R Christopher KB Pachler C . Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial . JAMA . (2014 ) 312 :1520Not reported30 . doi: 10.1001/jama.2014.13204 , 25268295
55. Amrein K Litonjua AA Moromizato T Quraishi SA Gibbons FK Pieber TR . Increases in pre-hospitalization serum 25 (OH) D concentrations are associated with improved 30-day mortality after hospital admission: a cohort study . Clin Nutr . (2016 ) 35 :514Not reported21 . doi: 10.1016/j.clnu.2015.03.020 , 25935851
Publication and source details

Original title: Association between serum 25-hydroxyvitamin D, nutritional status, and inflammatory markers in sepsis patients with and without sarcopenia

Hong Zheng; Chaoyong Bei; Zhongcheng Mo; Bing Wei

Frontiers in Medicine · 2026

* Correspondence: Bing Wei, 231351289@qq.com
†

These authors have contributed equally to this work and share first authorship

Copyright © 2026 Zheng, Bei, Mo and Wei.2026Zheng, Bei, Mo and Weihttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. The study was financially supported by the Open Project Program of Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University (No. GKLCDSM-20230101-03), the Open Project Program of Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University (No. GKLCDSM-KF2025-08), Guangxi Medical and Health Key Discipline Construction Project (Emergency Medicine, Gui Wei Ke Jiao Fa [2021] No. 8), Guangxi Medical and Health Key Cultivation Discipline Construction Project (Geriatric Medicine, Gui Wei Ke Jiao Fa [2023] No. 1), Project for Enhancing Young and Middle-Aged Teacher’s Basic Research Ability in the Colleges of Guangxi (No. 2025KY0509).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:26:29.145725+00:00

DOI: 10.3389/fmed.2026.1816016 · PMC13111296